Ribosome biogenesis in disease: new players and therapeutic targets
2023 · Signal Transduction and Targeted Therapy · 279 citations
https://doi.org/10.1038/s41392-022-01285-4
Y
Yu Zhang
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
184
Papers
4.3K
Citations
32
h-index
88
i10-index
Yu Zhang is an academic researcher from Novogene Bioinformatics Institute. The author has contributed to research in topics: CRISPR and Genetic Engineering & Osteoarthritis Treatment and Mechanisms & Cellular Mechanics and Interactions. The author has an h-index of 32, co-authored 157 publications.
ORCID: 0009-0005-4213-8045Papers by this author
worksFascin actin-bundling protein 1 in human cancer: Promising biomarker or therapeutic target?
2021 · Molecular Therapy — Oncolytics · 101 citations
https://doi.org/10.1016/j.omto.2020.12.014
The evolutionarily conserved MAPK/Erk signaling promotes ancestral T-cell immunity in fish via c-Myc–mediated glycolysis
2020 · Journal of Biological Chemistry · 93 citations
https://doi.org/10.1074/jbc.ra119.012231
Hierarchical macro-microporous WPU-ECM scaffolds combined with Microfracture Promote in Situ Articular Cartilage Regeneration in Rabbits
2020 · Bioactive Materials · 60 citations
https://doi.org/10.1016/j.bioactmat.2020.12.009
PEAL: Prior-embedded Explicit Attention Learning for Low-overlap Point Cloud Registration
2023 · 56 citations
https://doi.org/10.1109/cvpr52729.2023.01698
Using domain knowledge for robust and generalizable deep learning-based CT-free PET attenuation and scatter correction
2022 · Nature Communications · 54 citations
https://doi.org/10.1038/s41467-022-33562-9
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat